The latest trading day saw Hologic (HOLX) settling at $81.15, representing a -0.51% change from its previous close.
Hologic's upcoming fourth-quarter fiscal 2024 financial report is expected to reflect strength in core franchises.
Hologic Inc. President and CEO Steve MacMillan joins ‘Mornings with Maria' to discuss his company's latest technological strides in women's health.
On Monday, Hologic Inc HOLX agreed to acquire Gynesonics, Inc. for approximately $350 million.
Hologic enters Breast Cancer Awareness Month with the launch of the BustTheMyth campaign. This campaign is aimed at busting myths regarding breast health.
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
October is celebrated as breast cancer awareness month annually, and Hologic HOLX, this time too, honored the occasion by ringing the Nasdaq opening bell for the 18th consecutive time. While celebrating this yearly tradition, the company came into the limelight as it also introduced a comprehensive education campaign aimed at debunking common myths about breast cancer, mammograms and breast density.
Hologic (HOLX) closed at $80.26 in the latest trading session, marking a +0.48% move from the prior day.
Hologic (HOLX) reachead $79.77 at the closing of the latest trading day, reflecting a -0.98% change compared to its last close.
Steve MacMillan, Hologic chairman, president and CEO and Illumina chairman, joins 'Squawk Box' to discuss breast cancer awareness month, impact of AI on breast cancer detection, AI-powered diagnostics and the future of healthcare, and more.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.